Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Total Current Liabilities: 2020-2022

Historic Total Current Liabilities for Candel Therapeutics (CADL) over the last 3 years, with Dec 2022 value amounting to $5.6 million.

  • Candel Therapeutics' Total Current Liabilities rose 75.09% to $10.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $10.3 million, marking a year-over-year increase of 75.09%. This contributed to the annual value of $5.6 million for FY2022, which is 4.72% up from last year.
  • Candel Therapeutics' Total Current Liabilities amounted to $5.6 million in FY2022, which was up 4.72% from $5.4 million recorded in FY2021.
  • In the past 5 years, Candel Therapeutics' Total Current Liabilities registered a high of $5.6 million during FY2022, and its lowest value of $4.7 million during FY2020.
  • Its 3-year average for Total Current Liabilities is $5.2 million, with a median of $5.4 million in 2021.
  • Data for Candel Therapeutics' Total Current Liabilities shows a peak YoY climbed of 13.77% (in 2021) over the last 5 years.
  • Candel Therapeutics' Total Current Liabilities (Yearly) stood at $4.7 million in 2020, then climbed by 13.77% to $5.4 million in 2021, then rose by 4.72% to $5.6 million in 2022.